Compounds, compositions and methods are provided for treatment of diseases
or complications associated therewith, in which a selectin plays a role.
More specifically, particular glycomimetics and uses thereof are
described. For example, use of particular glycomimetics for treating
sickle cell disease or a cancer involving a selectin, or complications
associated with either, is described.